DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Listen to this Section


$3.60
+0.0900 ( +2.56% ) 15.6K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$3.60

Previous close


$3.51

Volume


15.6K

Market cap


$153.89M

Day range


$3.46 - $3.61

52 week range


$1.94 - $3.81

Insider Ownership Transactions

Total Amount Purchased: 1,805,047.00 | $ 6,498,169.20

Date Type Amount Purchased Purchaser
2024-07-01 Buy 1200000.00 STAHLBERG JAN
2024-07-01 Buy 1200000.00 Von Koch Thomas
2024-06-03 Sale -28472.00 Giuffre Randall Michael
2024-06-03 Sale -130000.00 Wambeke David J.
2024-06-03 Sale -36065.00 Pilnik Richard D.
2024-06-03 Sale -15000.00 Cundari Dominic R
2024-06-03 Sale -300000.00 Pauls Dietrich John
2024-06-03 Sale -28472.00 Semba Charles Pauling
2024-06-03 Sale -28472.00 Parsons James T.
2024-06-03 Sale -28472.00 Lewis Tanya

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 07, 2024
10-q Quarterly Reports 63 Aug 07, 2024
4 Insider transactions 1 Jul 01, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 49 Jun 26, 2024
8-k 8K-related 18 Jun 26, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.